Eden Research shares will be traded on the U.S. OTC market

Eden Research plc (LON:EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in global crop protection, animal health and consumer products industries, has announced its shares will be traded on the U.S. OTC market.

Eden’s shares will trade on the U.S. OTCQB Venture Market under the ticker EDNSF and will commence trading on 20th October 2021. The OTCQB listing will provide U.S. investors with the ability to trade in the Company’s ordinary shares in U.S. dollars and during U.S. market hours, thus allowing this group access to transact in Eden shares.

The U.S. capital market represents an exciting and untapped opportunity for Eden to diversify its shareholder base with a strong appeal to its active investor community. Eden is supporting this listing on OTCQB with new investor relations activity in the U.S. aimed at creating visibility for U.S. investors, broadening the Company’s shareholder base and improving stock liquidity.

Sean Smith, Chief Executive Officer of Eden Research plc, commented:

“Our OTCQB listing marks another important milestone for Eden as we seek to become a leader in biocontrol products. We are currently in the process of securing regulatory approval for Eden’s flagship products – Mevalone® and Cedroz™ – in the U.S., which will present significant market opportunities for the business in that region.

The U.S. has one of the largest organic food markets in the world, and its ongoing growth presents a significant opportunity for biopesticide market participants. As the only AIM-quoted company focused on biopesticides, we believe that Eden offers a unique proposition for U.S.-based investors seeking to participate in the rapid growth and promising future of sustainable agriculture.”

Eden was sponsored for its OTCQB listing by B. Riley Financial, a qualified third-party firm responsible for providing guidance on OTCQB requirements and recommending membership. Trading on the U.S. OTC market has no impact on existing Eden ordinary shares trading on the AIM market of the London Stock Exchange and no new ordinary shares will be issued as part of the cross-trade. Eden will continue to rely on the announcements and disclosures it makes to the London Stock Exchange and will have no Sarbanes-Oxley or SEC reporting requirements.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Eden Research

More articles like this

Eden Research

Pesticides in our is food increasing

There was a lovely photograph of Tamsin Borlase standing in Bosley Patch, her organic market garden, on the front page of the Henley Standard two weeks ago. Unfortunately, the story of her farm shop and livelihood being under threat wasn’t

Eden Research

Fertilisers and pesticides ‘confuse bees’

Agrochemical application can distort floral cues and modify behaviour in pollinators like bees, study confirms. Pollinators are less likely to land on flowers sprayed with fertilisers or pesticides as they can detect electric field changes around the flower,

Eden Research

Riding an organic wine wave

Organic wine is rising in popularity and consumers are expressing an increasing interest in what is in the wine they are drinking and how it is produced.  The Soil Association’s Organic Market Report 2022 revealed that 71% of

Eden Research

What’s the health impact of pesticides?

What are pesticides? Pesticides are highly toxic substances that humans use to kill unwanted plants or animals. These so-called pests typically threaten to damage or destroy agricultural crop or livestock but can also be found at home –

Eden Research

Eden Research granted US EPA regulatory approval

Eden Research plc (LON:EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, has announced that it has received regulatory approval from the United

Eden Research

Study finds high concentrations of pesticides in fruit leather

Whether as a hiking snack or part of a child’s lunch, fruit leather is a product loved for its convenience. But according to the Environmental Working Group (EWG),  fruit leathers can contain high concentrations of pesticides and consumers

Eden Research

Germany to stop exporting banned pesticides

Germany will ban from next spring the export to third countries of pesticides that are not authorised for the EU market and will also push for a bloc-wide export ban together with France. The German agriculture ministry is preparing

Eden Research

Eden Research appoints Richard Horsman as Non-Executive Director

Eden Research plc (LON:EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, has announced the appointment of Richard Horsman as Non-Executive Director,

Eden Research

Revenues rise at Oxford biotech Eden Research

Eden Research plc, the Oxford based sustainable biopesticide company which is developing plastic-free technology for use in global crop protection, animal health and consumer products, has revealed that it expected half year revenues to rise around 33 per cent,

No more posts to show